StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.3
  1. Startseite
  2. /Reaktion

Acetoin → (2RS,3SR)-2-(3-benzyloxy-5-fluorophenyl)-3-(tert-butyldimethylsilyloxy)butan-2-ol

HRID 654553
Drucken

Reaktionsgleichung

Reaktionsgleichung von HRID 654553
[Si:1]([O:8][CH:9]([CH3:13])[C:10](=[O:12])[CH3:11])([C:4]([CH3:7])([CH3:6])[CH3:5])([CH3:3])[CH3:2].OC(C)C(=O)C.[Si](Cl)(C(C)(C)C)(C)C.N1C=CN=C1.[CH2:33]([O:40][C:41]1[CH:42]=[C:43]([Mg]Br)[CH:44]=[C:45]([F:47])[CH:46]=1)[C:34]1[CH:39]=[CH:38][CH:37]=[CH:36][CH:35]=1.BrC1C=C(OCC2C=CC=CC=2)C=C(F)C=1.[Mg]>C(OCC)C.O1CCCC1>[CH2:33]([O:40][C:41]1[CH:42]=[C:43]([C:10]([OH:12])([CH:9]([O:8][Si:1]([C:4]([CH3:5])([CH3:7])[CH3:6])([CH3:3])[CH3:2])[CH3:13])[CH3:11])[CH:44]=[C:45]([F:47])[CH:46]=1)[C:34]1[CH:39]=[CH:38][CH:37]=[CH:36][CH:35]=1
KomponentenVersuchsvorschriftAufarbeitungQuellen und NachweiseNotizen zur Reaktion

Komponenten

10

Edukt 7

HCID 179AcetoinHCID 795ImidazoleHCID 28928tert-Butyldimethylsilyl chlorideHCID 5462224MagnesiumHCID 110418312-Butanone, 3-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-HCID 112545161-(Benzyloxy)-3-bromo-5-fluorobenzene
HCID 178505958
HCID 178505958, Verbindung

Produkt 1

HCID 19761503(2RS,3SR)-2-(3-benzyloxy-5-fluorophenyl)-3-(tert-butyldimethylsilyloxy)butan-2-olAusbeute 41 %

Reagenzien, Katalysatoren, Lösungsmittel 2

HCID 3283Diethyl EtherLösungsmittelHCID 8028TetrahydrofuranLösungsmittel3×

Versuchsvorschrift

A solution of 3-tert-butyldimethylsilyloxybutan-2-one (5.56 g; prepared by reacting 3-hydroxybutan-2-one with tert-butyldimethylsilyl chloride in diethyl ether and using imidazole as a suitable base) in tetrahydrofuran (5 ml) was added to a solution of 3-benzyloxy-5-fluorophenylmagnesium bromide [prepared by heating a mixture of benzyl 3-bromo-5-fluorophenyl ether (6.7 g), magnesium powder (0.58 g) and tetrahydrofuran (50 ml) to 40° C. for 1 hour] in tetrahydrofuran (50 ml) and the mixture was stirred at ambient temperature for 2.5 hours. The mixture was evaporated and the residue was partitioned between diethyl ether and water. The organic phase was washed with a saturated aqueous sodium chloride solution, dried (MgSO4) and evaporated. The residue was purified by column chromatography using a 3:2 v/v mixture of petroleum ether (b.p. 40°-60° C.) and methylene chloride as eluent. There was thus obtained an erythro isomer, (2RS,3SR)-2-(3-benzyloxy-5-fluorophenyl)-3-(tert-butyldimethylsilyloxy)butan-2-ol (3.8 g, 41%), as an oil; and a threo isomer, the corresponding (2RS,3RS)-isomer (1.73 g, 18%), as an oil.

Aufarbeitung

  1. customprepared
  2. customprepared
  3. temperatureby heating
  4. customThe mixture was evaporated
  5. customthe residue was partitioned between diethyl ether and water
  6. washThe organic phase was washed with a saturated aqueous sodium chloride solution
  7. dry with materialdried (MgSO4)
  8. customevaporated
  9. customThe residue was purified by column chromatography
  10. additiona 3:2 v/v mixture of petroleum ether (b.p. 40°-60° C.) and methylene chloride as eluent

Quellen und Nachweise

ORD-Eintrag
ord-efae501d2a4f4bacb39b4fd990cc6ca9
Quelldatensatz
uspto-grants-1992_07
DOI
10.6084/m9.figshare.5104873.v1
Patentnummer
US05132328

Notizen zur Reaktion

Auf dieser SeiteKomponentenVersuchsvorschriftAufarbeitungQuellen und NachweiseNotizen zur Reaktion